Tag Archives: Johnson & Johnson

European Commission Investigates J&J, Novartis

By Stephanie Sutton. The European Commission claims that Johnson & Johnson and Novartis may have breached European antitrust rules.
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , | Leave a comment

Johnson & Johnson Slammed Over Manufacturing Practices, Phantom Recall

In 1982, Johnson & Johnson garnered an enduring amount of goodwill when, seemingly without any thought of lost profit, it immediately yanked Tylenol from the shelves nationwide after learning someone was slipping cyanide into bottles in Chicago. The company’s sure and swift PR response became the model for crisis management for the corporate world. But […]
Posted in Corporate Responsibility | Also tagged , , , , , , , , , | 3 Comments

A Critical Path to New TB Treatments

Image via Wikipedia FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and non-profit organizations designed to fast-track modern combination treatments for tuberculosis. Where once it took more than two decades to create new therapies for TB, this collaboration is expected to produce working treatments in less than six years, […]
Posted in R&D | Also tagged , , , , , , | 2 Comments

Pharma and Haiti: Can Altruism Backfire?

Guest blog by Pharm Exec Europe‘s Jacky Law. Pharma companies are responding swiftly to the recent earthquake in Haiti with millions of dollars in cash and drugs. GlaxoSmithKline boasted, for example, that its initial $1.2 million offering of medicines — mainly oral and topical antibiotics — was on the first airlift to the Caribbean island […]
Posted in Corporate Responsibility, Global, Guest Blog, News | Also tagged , , , , | Leave a comment

Feds Chase Down Faulty Skincare Promos

FDA’s Division of Drug Marketing Communications, this week, posted a slew of warning and untitled letters to pharma firms for misleading skincare advertisements. Johnson & Johnson, Galderma, and Allergan each received a letter documenting complaints ranging from false advertising to unsubstantial efficacy claims. J&J received a violation letter in response to a journal ad for […]
Posted in FDA, Marketing | Also tagged , , , | 2 Comments
  • Categories

  • Meta